Oral Pathology Asynchronous Telementoring Pilot Study

Status Completed

Clinical Trial Summary

The purpose of the proposed research project is to evaluate and enhance the feasibility and acceptability of integrating a tele-mentoring component into the identification of oral lesions at the 6 dental clinics of Family Health Centers at NYU Langone (FHC), a Federally Qualified Health Center (FQHC) in Brooklyn, NY.

Clinical Trial Description

The tele-mentoring intervention involves training dental faculty members and residents to use intraoral cameras to take photographs of oral lesions and place them in the Dentrix electronic health record (EHR), along with descriptions of the lesions. Using a mixed-methods approach, the study will evaluate and enhance the feasibility and acceptability of integrating a tele-mentoring component into the identification of oral lesions at the 6 FHC dental clinics. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04166214
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Completed
Phase	N/A
Start date	July 14, 2020
Completion date	November 23, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06031337` - Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
Completed	`NCT00158678` - IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC	Phase 3
Completed	`NCT00933387` - A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma	Phase 2
Enrolling by invitation	`NCT05030597` - Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma	N/A
Completed	`NCT03682562` - Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
Recruiting	`NCT03684707` - Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions	Phase 4
Recruiting	`NCT06130332` - Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)	Phase 2
Recruiting	`NCT04372914` - Prevention of Oral DNA Damage by Black Raspberries	N/A
Active, not recruiting	`NCT03529422` - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN	Phase 2
Recruiting	`NCT03686020` - Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
Not yet recruiting	`NCT06060288` - Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
Withdrawn	`NCT00951470` - Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema	N/A
Completed	`NCT00964977` - Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.	Phase 3
Completed	`NCT01418118` - Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery	Phase 4
Active, not recruiting	`NCT00232960` - Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC	N/A
Recruiting	`NCT05429099` - Mandibular Reconstruction Preplanning (ViPMR)	Phase 2/Phase 3
Completed	`NCT04614896` - Use of Ultrasound for Measuring Size of Oral Tongue Cancers	N/A
Recruiting	`NCT03685409` - Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions	Phase 3
Completed	`NCT00402779` - Erlotinib Prevention of Oral Cancer (EPOC)	Phase 3
Recruiting	`NCT05153733` - Improved Implant for Reconstruction Purposes After Mandibular Resection	N/A